Markets:

Overview

News

Currencies

International

Treasuries

Paratek Pharmaceuticals, Inc. - Common Stock (NQ:PRTK)

N/A UNCHANGED

Last Price Updated: 4:00 PM EDT, Sep 20, 2023 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Paratek Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 Next >

12 Health Care Stocks Moving In Friday's After-Market Session ↗

August 06, 2021

Gainers Nuwellis (NASDAQ:NUWE) shares in...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

August 05, 2021

Gainers Ensysce Biosciences (NASDAQ:ENSC) shares rose 42.78% to $5.84 during Thursday's pre-market session. The company's market cap stands at $141.7 million....

Via Benzinga

The Daily Biotech Pulse: Merck Reports Positive Keytruda Readout, Moderna Slips Despite Q2 Beat, Bayer To Buy Vividion For Up To $2B, GlycoMimetics Gets New CEO ↗

August 05, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 4) Absci, CORP (NASDAQ: ABSI) (...

Via Benzinga

26 Stocks Moving in Thursday's Pre-Market Session ↗

August 05, 2021

Gainers Ensysce Biosciences, Inc. (NASDAQ: ENSC) shares rose 34% to $5.48 in pre-market trading after dropping around 15% on Wednesday. Ensysce Biosciences recently appointed...

Via Benzinga

Paratek Pharma - Trending Stock ↗

June 10, 2021

Revenue expected to grow 270.10% this year and another 16.20% next year. Earnings estimated to increase 92.00% this year and an additional 61.10% next year.

Via Talk Markets

Paratek Stock Is Trading Higher As CDC Adds Nuzyra As Recommended Antibiotic For Plague Treatment ↗

August 05, 2021

The Center for Disease Control and Prevention (CDC) has added Paratek Pharmaceuticals Inc's (NASDAQ: PRTK) antibiotic Nuzyra (omadacycline) as an...

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

June 21, 2021

Gainers MediciNova (NASDAQ:MNOV) shares moved upwards by 50.79% to $5.67 during Monday's pre-market session. The market value of their outstanding shares is at $276.5...

Via Benzinga

10 Biggest Price Target Changes For Monday ↗

June 21, 2021

SVB Leerink raised Natera, Inc. (NASDAQ:NTRA) pr...

Via Benzinga

48 Biggest Movers From Yesterday ↗

June 17, 2021

Gainers Gaucho Group Holdings, Inc. (NASDAQ: VINO) shares jumped 95.1% to close at $7.98 on Wednesday. Gaucho Group highlighted the launch of its Amazon Storefront. Orphazyme A/S...

Via Benzinga

Mid-Afternoon Market Update: Dow Tumbles Over 300 Points; Federal Reserve Maintains Interest Rates ↗

June 16, 2021

Toward the end of trading Wednesday, the Dow traded down 0.92% to 33,983.29 while the NASDAQ fell 0.68% to 13,977.59. The S&P also fell, dropping 0.74% to 4,215.21. The U.S....

Via Benzinga

Topics Economy Stocks

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

June 16, 2021

Gainers Orphazyme (NASDAQ:ORPH) shares moved upwards by 72.49% to $17.34 during Wednesday's regular session. As of 12:31 EST, Orphazyme's stock is trading at a...

Via Benzinga

Why Paratek Pharmaceuticals Stock Is Sinking Today ↗

June 16, 2021

The company reduced its 2021 revenue outlook.

Via The Motley Fool

Mid-Day Market Update: Dow Falls 40 Points; Aprea Therapeutics Shares Surge ↗

June 16, 2021

Midway through trading Wednesday, the Dow traded down 0.12% to 34,259.48 while the NASDAQ rose 0.20% to 14,100.31. The S&P also fell, dropping 0.05% to 4,244.41. The U.S. has...

Via Benzinga

Topics Stocks

36 Stocks Moving In Wednesday's Mid-Day Session ↗

June 16, 2021

Gainers Opthea Limited (NASDAQ: OPT) shares surged 50.7% to $13.28. The company recently appointed Mrs. Karen Adams as Vice President of Finance and Company Secretary. Kindred...

Via Benzinga

Paratek Launches Mid-Stage NTM Program With Nuzyra, Second Procurement Under BARDA Pact Expected In 2H 2022 ↗

June 16, 2021

Paratek Pharmaceuticals Inc (NASDAQ: PRTK) has initiated Phase 2b trial evaluating Nuzyra (omadacycline) for Nontuberculous Mycobacterial (NTM) Pulmonary Disease...

Via Benzinga

The Daily Biotech Pulse: Vertex Shelves Mid-Stage Study, Precigen & Novan Jump On Data, Hematology Conference, Janux Debuts ↗

June 11, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 10) Alexion Pharmaceuticals,...

Via Benzinga

The Daily Biotech Pulse: US To Procure 500M Pfizer-BioNTech Vaccine Doses For Donation, Verona Out-Licenses COPD Drug, Nautilus Lists Through SPAC Deal ↗

June 10, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 9) Aethlon Medical, Inc. (...

Via Benzinga

The Daily Biotech Pulse: Lyra Gains On Positive Regulatory Outcome, FDA Nod For Pfizer's Prevnar Vaccine, Merck Inks COVID-19 Treatment Supply Deal With US ↗

June 09, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 8) Agios Pharmaceuticals, Inc...

Via Benzinga

Stocks That Hit 52-Week Highs On Tuesday ↗

June 08, 2021

Tuesday morning saw 244 companies set new 52-week highs. Interesting Highlights: The largest company by market cap to set a new 52-week high was Alphabet (NASDAQ:...

Via Benzinga

The Daily Biotech Pulse: Merck, AstraZeneca, Novartis Among Early Presenters At ASCO, Sanofi Strikes Breast Cancer Study Pact ↗

June 04, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 3) BioCryst Pharmaceuticals,...

Via Benzinga

The Daily Biotech Pulse: Merck Completes Organon Spin-Off, Auris Repositions As RNA Therapeutic Company With Trasir Purchase, Replimune's Readout ↗

June 03, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 2) BioCryst Pharmaceuticals,...

Via Benzinga

The Daily Biotech Pulse: FDA Nod For Novartis, iRhythm CEO Quits Abruptly, Moderna Inks Vaccine Supply Agreements ↗

June 02, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 1) Anika Therapeutics, Inc. (...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

June 02, 2021

Gainers Constellation (NASDAQ:CNST) shares moved upwards by 66.55% to $33.71 during Wednesday's pre-market session. The market value of their outstanding shares is at...

Via Benzinga

Why Paratek Pharmaceuticals Crushed the Market Today ↗

June 01, 2021

The company gets off to a roaring start in June with an important FDA nod.

Via The Motley Fool

68 Biggest Movers From Yesterday ↗

June 02, 2021

Gainers Orbital Energy Group, Inc. (NASDAQ: OEG) shares surged 115.2% to close at $7.64 on Tuesday after the company announced its subsidiary, Gibson Technical Services, reached...

Via Benzinga

Paratek's Stock Gains After Nuzyra's Oral Regime Wins FDA Approval For Pneumonia ↗

June 01, 2021

The FDA has approved Paratek Pharmaceuticals Inc's (NASDAQ: PRTK) supplemental marketing application for the oral-only dosing regimen of Nuzyra for Community-...

Via Benzinga

Stocks That Hit 52-Week Highs On Tuesday ↗

June 01, 2021

Tuesday's morning session saw 391 companies set new 52-week highs. Noteworthy Mentions: The largest company by market cap to set a new 52-week high was JPMorgan...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

June 01, 2021

Gainers Paratek Pharmaceuticals (NASDAQ:PRTK) stock increased by 12.65% to $9.26 during Tuesday's pre-market session. The company's market cap stands at $434.5...

Via Benzinga

Paratek Pharmaceuticals (PRTK) Q1 2021 Earnings Call Transcript ↗

May 17, 2021

PRTK earnings call for the period ending March 31, 2021.

Via The Motley Fool

Topics Earnings

ROCE Insights For Paratek Pharmaceuticals ↗

May 17, 2021

Paratek Pharmaceuticals (NASDAQ:PRTK) reported Q1 sales of $16.43 million. Earnings fell to a loss of $14.22 million, resulting in a 18.89% decrease from last quarter. In Q4,...

Via Benzinga

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.